OpenAI’s recent private funding round negotiations, targeting a $1.25 trillion pre-money valuation after scaling back from $1.4 trillion amid investor pushback, anchor the dispersed Polymarket odds across sub-$2 trillion buckets. Heightened scrutiny of AI infrastructure costs, revenue recognition differences versus peers, and elevated interest rates have tempered enthusiasm, while competitive pressure from Anthropic’s expected November 2026 IPO at a higher target adds uncertainty. Sam Altman has cited AI safety priorities in delaying the listing to 2027 following a confidential SEC filing, leaving outcomes sensitive to the success of the current $30 billion raise, upcoming economic data releases, and broader tech market sentiment heading into next year.